Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2016 | 1 |
2019 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29.
Lancet Oncol. 2019.
PMID: 31474354
Clinical Trial.
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.
Bønløkke S, Stougaard M, Sorensen BS, Booth BB, Høgdall E, Nyvang GB, Lindegaard JC, Blaakær J, Bertelsen J, Fuglsang K, Strube ML, Lenz S, Steiniche T.
Bønløkke S, et al. Among authors: nyvang gb.
Cells. 2022 Jul 11;11(14):2170. doi: 10.3390/cells11142170.
Cells. 2022.
PMID: 35883612
Free PMC article.
Item in Clipboard
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group.
Colombo N, et al.
Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.
Br J Cancer. 2023.
PMID: 36759720
Free PMC article.
Clinical Trial.
Item in Clipboard
Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
Bønløkke S, Steiniche T, Sorensen BS, Nyvang GB, Lindegaard JC, Blaakær J, Bertelsen J, Fuglsang K, Strube ML, Lenz S, Stougaard M.
Bønløkke S, et al. Among authors: nyvang gb.
Mol Oncol. 2024 May;18(5):1231-1244. doi: 10.1002/1878-0261.13538. Epub 2023 Nov 1.
Mol Oncol. 2024.
PMID: 37853962
Free PMC article.
Item in Clipboard
Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A, Schledermann D, Nyvang GB, Mogensen O, Herrstedt J; Academy of Geriatric Cancer Research (AgeCare).
Ør Knudsen A, et al. Among authors: nyvang gb.
Acta Oncol. 2016;55 Suppl 1:65-73. doi: 10.3109/0284186X.2015.1115119. Epub 2016 Jan 19.
Acta Oncol. 2016.
PMID: 26784001
Item in Clipboard
Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity.
Korsholm LM, Kjeldsen M, Perino L, Mariani L, Nyvang GB, Kristensen E, Bagger FO, Mirza MR, Rossing M.
Korsholm LM, et al. Among authors: nyvang gb.
JCO Precis Oncol. 2024 Feb;8:e2300483. doi: 10.1200/PO.23.00483.
JCO Precis Oncol. 2024.
PMID: 38427930
Free PMC article.
Item in Clipboard
From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer.
Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC.
Tanderup K, et al. Among authors: nyvang gb.
Radiother Oncol. 2010 Feb;94(2):173-80. doi: 10.1016/j.radonc.2010.01.001.
Radiother Oncol. 2010.
PMID: 20138380
Item in Clipboard
Cite
Cite